The report provides a detailed analysis essential for establishing a raloxifene production plant. It encompasses all critical aspects necessary for raloxifene production, including the cost of raloxifene production, raloxifene plant cost, raloxifene production costs, and the overall raloxifene production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a raloxifene production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Raloxifene is a selective estrogen receptor modulator (SERM) that is used to prevent and treat postmenopausal osteoporosis. It works by mimicking estrogen's bone-protective effects, increasing bone mineral density, and reducing vertebral fracture risk. It is taken as a standard dose of 60 mg daily alongside calcium and vitamin D supplementation. It also lowers the risk of invasive breast cancer by 60-80% in postmenopausal women with osteoporosis or high risk. It works as an estrogen antagonist in breast tissue to inhibit cancer cell growth. It also shows applications in male osteoporosis, prostate cancer adjunct therapy with antiandrogens, and schizophrenia symptom relief in postmenopausal women. Its common side effects include hot flashes, leg cramps, joint/muscle pain, flu-like symptoms, peripheral edema, insomnia, and vaginal discharge.
The market for raloxifene is influenced by increasing postmenopausal osteoporosis cases. The demand for breast cancer risk reduction, ageing populations, especially in the Asia-Pacific regions, contributes to its market demand. The rise in women's health programs promoting preventive care fuels its market growth.
The preference for low-cost generics acquired via public tenders, influenced by active pharmaceutical ingredient supplies from India and China, affects industrial raloxifene procurement. The regulatory approvals from the FDA and EMA, pricing competition between branded products and off-patent versions, along with bulk hospital and clinic orders impacts its sourcing. Other factors like side effect awareness, favouring alternatives and trends that favour combination therapies and localised production, affect its market dynamics.
Raw Material for Raloxifene Production
According to the raloxifene production plant project report, the key raw materials used in the production of raloxifene include 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene | pyridine hydrochloride | acetic anhydride | 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride.
Production Process of Raloxifene
The extensive raloxifene production cost report consists of the following major industrial production process:
- From 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene: The production process of raloxifene involves a multi-step synthesis. It starts with the demethylation of 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene using pyridine hydrochloride to produce 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophene. This dihydroxy intermediate is then protected via acetylation with acetic anhydride to form 6-acetoxy-2-(4-acetoxyphenyl)benzo[b]thiophene. Next, Friedel-Crafts acylation is performed using 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride and aluminium trichloride in a solvent like dichloromethane. Finally, deprotection occurs through alkaline hydrolysis with sodium hydroxide in alcohol, followed by acidification with concentrated hydrochloric acid to yield the pure raloxifene hydrochloride.
Raloxifene has the molecular formula of (free base) C28H27NO4S with a molecular weight of 473.58 g/mol. Its hydrochloride salt has the molecular formula of C28H27NO4S- HCl with a molecular weight of 510.05 g/mol. It is an off-white to pale-yellow crystalline solid that is slightly soluble in water. It has the melting points of 143–147 degree Celsius (base) or 250–253 degree Celsius/258 degree Celsius (HCl salt). It has a density of around 1.29 g/cm³ with a boiling point of 728 degree Celsius. It has a logP value of 5.5 that makes it lipophilic. It requires storage at cool temperatures and is chemically stable but sensitive to light and heat.